BioSpace News Archive

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today reported financial results for the fourth quarter and full year ended December 31, 2019.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three and 12 months ended December 31, 2019, and provides an update on its business progress.

The National Kidney Foundation (NKF) showcased this week a new study for a drug treatment to address metabolic acidosis in patients with kidney disease which significantly improved how patients felt and functioned.

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Dr. Marie Mazur, has been appointed to its Board of Directors.

Today, the National Kidney Foundation (NKF) showcased a global study designed to understand the experimental immunosuppressant drug Voclosporin as a treatment for patients with lupus kidney disease.

To facilitate inpatient capacity across the health care system during the COVID-19 state of emergency, Blue Cross Blue Shield of Massachusetts has removed prior authorization requirements and moved to a notification-only requirement for inpatient levels of care including Acute, Long Term Acute, Acute and Subacute Rehabilitation, and Skilled Nursing Facility admissions.

The World Health Organization is working with scientists across the globe on at least 20 different coronavirus vaccines with some already in clinical trials in record time — just 60 days after sequencing the gene, according to reports from CNBC.

Oncology Scientific Advisory Board to support advancement of Immuneering’s drug programs modulating the RAS/MAPK signaling pathway in cancer

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on market monitoring solution for a biopharmaceutical contract manufacturing firm.

St. George’s University announced that more than 1,060 of its students secured residencies in the 2020 match cycle.